FDA approves once-daily Idvynso tablet for treating HIV

The U.S. Food and Drug Administration has approved Merck's Idvynso (doravirine/islatravir), a new, once-daily, two-drug single tablet for the treatment of HIV-1 infection in adults to replace the current antiretroviral regimen ...

How disinfectants influence microbes across hospital rooms

Just because a topical antiseptic is swabbed on the skin doesn't mean it stays on the skin. In a new study, Northwestern University scientists studied how a powerful antiseptic, called chlorhexidine, affects bacteria in hospital ...

page 5 from 40